Inj. Ferric Carboxymaltose (FCM) Vs Iron Isomaltoside (IIM) in treatment of iron deficiency anemia in Pregnancy (Antenatal)
Not Applicable
Completed
- Conditions
- Health Condition 1: O20-O29- Other maternal disorders predominantly related to pregnancy
- Registration Number
- CTRI/2020/05/025180
- Lead Sponsor
- Bhawna Garg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 140
Inclusion Criteria
Antepartum women whose Hemoglobin is in range of 7 to 10.9 gram per decilitre
Women in second trimester of pregnancy (14- to 22 weeks)
Exclusion Criteria
Women not willing to participate
Women with less than 14 weeks of gestation
Women in labor
Known case of Thalassemia or Megaloblastic anemia
Women who have a history or known allergy to parenteral iron infusion.
Women with normal serum ferritin levels
history of any liver disease
history of any Autoimmune disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method